ReP USP - Resultado da busca

Artigo de periodico
Cocaine use disorder effects on blood oxytocin levels and OXTR DNA methylation (2023)
Souza, Manasses Soares; Sanvicente-Vieira, Breno; Zaparte, Aline; Baptista, Talita; Nagai, Maria Aparecida ; Mangone, Flavia Rotea; Pavanelli, Ana Carolina; Viola, Thiago Wendt; Grassi-oliveira, Rodrigo
Source: Neuroscience letters. Unidade: FM
Subjects: RECEPTORES DE NEUROTRANSMISSORES, OCITOCINA, METILAÇÃO DE DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Manasses Soares et al. Cocaine use disorder effects on blood oxytocin levels and OXTR DNA methylation. Neuroscience letters, v. 816, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57385. Acesso em: 16 nov. 2024.
APA
Souza, M. S., Sanvicente-Vieira, B., Zaparte, A., Baptista, T., Nagai, M. A., Mangone, F. R., et al. (2023). Cocaine use disorder effects on blood oxytocin levels and OXTR DNA methylation. Neuroscience letters, 816. doi:10.1016/j.neulet.2023.137506
NLM
Souza MS, Sanvicente-Vieira B, Zaparte A, Baptista T, Nagai MA, Mangone FR, Pavanelli AC, Viola TW, Grassi-oliveira R. Cocaine use disorder effects on blood oxytocin levels and OXTR DNA methylation [Internet]. Neuroscience letters. 2023 ; 816[citado 2024 nov. 16 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57385
Vancouver
Souza MS, Sanvicente-Vieira B, Zaparte A, Baptista T, Nagai MA, Mangone FR, Pavanelli AC, Viola TW, Grassi-oliveira R. Cocaine use disorder effects on blood oxytocin levels and OXTR DNA methylation [Internet]. Neuroscience letters. 2023 ; 816[citado 2024 nov. 16 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57385
Artigo de periodico
Interrelated but Not Time-Aligned Response in Myogenic Regulatory Factors Demethylation and mRNA Expression after Divergent Exercise Bouts (2023)
Telles, Guilherme Defante; Libardi, Cleiton Augusto ; Conceição, Miguel Soares ; Vechin, Felipe Cassaro ; Lixandrão, Manoel Emílio ; Mangone, Flavia Regina Rotea; Pavanelli, Ana Carolina; Nagai, Maria Aparecida ; Camera, Donny Michael; Hawley, John A; Ugrinowitsch, Carlos
Source: Medicine and Science in Sports and Exercise. Unidades: FM, EEFE
Subjects: METILAÇÃO DE DNA, RNA MENSAGEIRO, EPIGÊNESE GENÉTICA, EXERCÍCIO FÍSICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TELLES, Guilherme Defante et al. Interrelated but Not Time-Aligned Response in Myogenic Regulatory Factors Demethylation and mRNA Expression after Divergent Exercise Bouts. Medicine and Science in Sports and Exercise, v. 55, n. 2, p. 199-208, 2023Tradução . . Disponível em: https://doi.org/10.1249/MSS.0000000000003049. Acesso em: 16 nov. 2024.
APA
Telles, G. D., Libardi, C. A., Conceição, M. S., Vechin, F. C., Lixandrão, M. E., Mangone, F. R. R., et al. (2023). Interrelated but Not Time-Aligned Response in Myogenic Regulatory Factors Demethylation and mRNA Expression after Divergent Exercise Bouts. Medicine and Science in Sports and Exercise, 55( 2), 199-208. doi:10.1249/MSS.0000000000003049
NLM
Telles GD, Libardi CA, Conceição MS, Vechin FC, Lixandrão ME, Mangone FRR, Pavanelli AC, Nagai MA, Camera DM, Hawley JA, Ugrinowitsch C. Interrelated but Not Time-Aligned Response in Myogenic Regulatory Factors Demethylation and mRNA Expression after Divergent Exercise Bouts [Internet]. Medicine and Science in Sports and Exercise. 2023 ; 55( 2): 199-208.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1249/MSS.0000000000003049
Vancouver
Telles GD, Libardi CA, Conceição MS, Vechin FC, Lixandrão ME, Mangone FRR, Pavanelli AC, Nagai MA, Camera DM, Hawley JA, Ugrinowitsch C. Interrelated but Not Time-Aligned Response in Myogenic Regulatory Factors Demethylation and mRNA Expression after Divergent Exercise Bouts [Internet]. Medicine and Science in Sports and Exercise. 2023 ; 55( 2): 199-208.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1249/MSS.0000000000003049
Artigo de periodico
Interrelated but not time-aligned response in myogenic regulatory factors demethylation and mRNA expression after divergent Exercise Bouts (2023)
Telles, Guilherme Defante; Libardi, Cleiton Augusto; Conceicao, Miguel Soares; Vechin, Felipe Cassaro; Lixandrao, Manoel Emilio; Mangone, Flavia Regina Rotea; Pavanelli, Ana Carolina; Nagai, Maria Aparecida ; Camera, Donny Michael; Hawley, John A; Ugrinowitsch, Carlos
Source: Medicine & science in sports & exercise. Unidade: FM
Subjects: EXERCÍCIOS DE RESISTÊNCIA MUSCULAR, PROLIFERAÇÃO CELULAR, METILAÇÃO DE DNA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TELLES, Guilherme Defante et al. Interrelated but not time-aligned response in myogenic regulatory factors demethylation and mRNA expression after divergent Exercise Bouts. Medicine & science in sports & exercise, v. 55, n. 2, p. 199-208, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/52913. Acesso em: 16 nov. 2024.
APA
Telles, G. D., Libardi, C. A., Conceicao, M. S., Vechin, F. C., Lixandrao, M. E., Mangone, F. R. R., et al. (2023). Interrelated but not time-aligned response in myogenic regulatory factors demethylation and mRNA expression after divergent Exercise Bouts. Medicine & science in sports & exercise, 55( 2), 199-208. doi:10.1249/MSS.0000000000003049
NLM
Telles GD, Libardi CA, Conceicao MS, Vechin FC, Lixandrao ME, Mangone FRR, Pavanelli AC, Nagai MA, Camera DM, Hawley JA, Ugrinowitsch C. Interrelated but not time-aligned response in myogenic regulatory factors demethylation and mRNA expression after divergent Exercise Bouts [Internet]. Medicine & science in sports & exercise. 2023 ; 55( 2): 199-208.[citado 2024 nov. 16 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52913
Vancouver
Telles GD, Libardi CA, Conceicao MS, Vechin FC, Lixandrao ME, Mangone FRR, Pavanelli AC, Nagai MA, Camera DM, Hawley JA, Ugrinowitsch C. Interrelated but not time-aligned response in myogenic regulatory factors demethylation and mRNA expression after divergent Exercise Bouts [Internet]. Medicine & science in sports & exercise. 2023 ; 55( 2): 199-208.[citado 2024 nov. 16 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52913
Artigo de periodico
The transcriptomic portrait of locally advanced breast cancer and its prognostic value in a multi-country cohort of Latin American patients (2022)
Llera, Andrea Sabina; Abdelhay, Eliana Saul Furquim Werneck; Artagaveytia, Nora; Daneri-Navarro, Adrian; Muller, Bettina; Velazquez, Carlos; Alcoba, Elsa B; Alonso, Isabel; Quinta, Daniela B. Alves da; Nagai, Maria Aparecida
Source: Frontiers in oncology. Unidade: FM
Subjects: NEOPLASIAS MAMÁRIAS, RECIDIVA LOCAL DE NEOPLASIA, HETEROGENEIDADE, AMÉRICA LATINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LLERA, Andrea Sabina et al. The transcriptomic portrait of locally advanced breast cancer and its prognostic value in a multi-country cohort of Latin American patients. Frontiers in oncology, v. 12, 2022Tradução . . Disponível em: https://doi.org/10.3389/fonc.2022.835626. Acesso em: 16 nov. 2024.
APA
Llera, A. S., Abdelhay, E. S. F. W., Artagaveytia, N., Daneri-Navarro, A., Muller, B., Velazquez, C., et al. (2022). The transcriptomic portrait of locally advanced breast cancer and its prognostic value in a multi-country cohort of Latin American patients. Frontiers in oncology, 12. doi:10.3389/fonc.2022.835626
NLM
Llera AS, Abdelhay ESFW, Artagaveytia N, Daneri-Navarro A, Muller B, Velazquez C, Alcoba EB, Alonso I, Quinta DBA da, Nagai MA. The transcriptomic portrait of locally advanced breast cancer and its prognostic value in a multi-country cohort of Latin American patients [Internet]. Frontiers in oncology. 2022 ; 12[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fonc.2022.835626
Vancouver
Llera AS, Abdelhay ESFW, Artagaveytia N, Daneri-Navarro A, Muller B, Velazquez C, Alcoba EB, Alonso I, Quinta DBA da, Nagai MA. The transcriptomic portrait of locally advanced breast cancer and its prognostic value in a multi-country cohort of Latin American patients [Internet]. Frontiers in oncology. 2022 ; 12[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fonc.2022.835626
Artigo de periodico
Socioeconomic, clinical, and molecular features of breast cancer influence overall survival of Latin American Women (2022)
Almeida, Liz Maria de; Cortes, Sandra; Vilensky, Marta; Valenzuela, Olivia; Cortes-Sanabria, Laura; Souza, Mirian de; Barbeito, Rafael Alonso; Abdelhay, Eliana; Artagaveytia, Nora; Nagai, Maria Aparecida
Source: Frontiers in oncology. Unidade: FM
Subjects: NEOPLASIAS MAMÁRIAS, FATORES SOCIOECONÔMICOS, MULHERES, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Liz Maria de et al. Socioeconomic, clinical, and molecular features of breast cancer influence overall survival of Latin American Women. Frontiers in oncology, v. 12, 2022Tradução . . Disponível em: https://doi.org/10.3389/fonc.2022.845527. Acesso em: 16 nov. 2024.
APA
Almeida, L. M. de, Cortes, S., Vilensky, M., Valenzuela, O., Cortes-Sanabria, L., Souza, M. de, et al. (2022). Socioeconomic, clinical, and molecular features of breast cancer influence overall survival of Latin American Women. Frontiers in oncology, 12. doi:10.3389/fonc.2022.845527
NLM
Almeida LM de, Cortes S, Vilensky M, Valenzuela O, Cortes-Sanabria L, Souza M de, Barbeito RA, Abdelhay E, Artagaveytia N, Nagai MA. Socioeconomic, clinical, and molecular features of breast cancer influence overall survival of Latin American Women [Internet]. Frontiers in oncology. 2022 ; 12[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fonc.2022.845527
Vancouver
Almeida LM de, Cortes S, Vilensky M, Valenzuela O, Cortes-Sanabria L, Souza M de, Barbeito RA, Abdelhay E, Artagaveytia N, Nagai MA. Socioeconomic, clinical, and molecular features of breast cancer influence overall survival of Latin American Women [Internet]. Frontiers in oncology. 2022 ; 12[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fonc.2022.845527
Parte de monografia/livro
Modulação da expressâo gênica e epignética (2022)
Santos, Nathalia Leal; Nagai, Maria Aparecida ; Furuya, Tatiane Katsue
Source: Oncologia - da molécula à clínica. Unidade: FM
Subjects: NEOPLASIAS, EXPRESSÃO GÊNICA, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Nathalia Leal e NAGAI, Maria Aparecida e FURUYA, Tatiane Katsue. Modulação da expressâo gênica e epignética. Oncologia - da molécula à clínica. Tradução . São Paulo: Editora dos Editores, 2022. . . Acesso em: 16 nov. 2024.
APA
Santos, N. L., Nagai, M. A., & Furuya, T. K. (2022). Modulação da expressâo gênica e epignética. In Oncologia - da molécula à clínica. São Paulo: Editora dos Editores.
NLM
Santos NL, Nagai MA, Furuya TK. Modulação da expressâo gênica e epignética. In: Oncologia - da molécula à clínica. São Paulo: Editora dos Editores; 2022. [citado 2024 nov. 16 ]
Vancouver
Santos NL, Nagai MA, Furuya TK. Modulação da expressâo gênica e epignética. In: Oncologia - da molécula à clínica. São Paulo: Editora dos Editores; 2022. [citado 2024 nov. 16 ]
Artigo de periodico
Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes (2022)
Pavanelli, Ana Carolina; Mangone, Flavia Rotea; Yoganathan, Piriya; Bessa, Simone Aparecida; Nonogaki, Suely; Osorio, Cynthia A. B. de Toledo; Andrade, Victor Piana de; Soares, Ibere Cauduro; Mello, Evandro Sobrosa de; Mulligan, Lois M.; Nagai, Maria Aparecida
Source: Breast cancer research and treatment. Unidade: FM
Subjects: NEOPLASIAS MAMÁRIAS, ANTINEOPLÁSICOS, TERAPIA DE REPOSIÇÃO DE ESTRÓGENOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAVANELLI, Ana Carolina et al. Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes. Breast cancer research and treatment, v. 192, n. 1, p. 43-52, 2022Tradução . . Disponível em: https://doi.org/10.1007/s10549-021-06452-9. Acesso em: 16 nov. 2024.
APA
Pavanelli, A. C., Mangone, F. R., Yoganathan, P., Bessa, S. A., Nonogaki, S., Osorio, C. A. B. de T., et al. (2022). Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes. Breast cancer research and treatment, 192( 1), 43-52. doi:10.1007/s10549-021-06452-9
NLM
Pavanelli AC, Mangone FR, Yoganathan P, Bessa SA, Nonogaki S, Osorio CAB de T, Andrade VP de, Soares IC, Mello ES de, Mulligan LM, Nagai MA. Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes [Internet]. Breast cancer research and treatment. 2022 ; 192( 1): 43-52.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s10549-021-06452-9
Vancouver
Pavanelli AC, Mangone FR, Yoganathan P, Bessa SA, Nonogaki S, Osorio CAB de T, Andrade VP de, Soares IC, Mello ES de, Mulligan LM, Nagai MA. Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes [Internet]. Breast cancer research and treatment. 2022 ; 192( 1): 43-52.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s10549-021-06452-9
Artigo de periodico
Circulating plasma miRNA and clinical/hemodynamic characteristics provide additional predictive information about acute pulmonary thromboembolism, chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension (2021)
Fabro, Alexandre Todorovic ; Machado-Rugolo, Juliana ; Baldavira, Camila Machado ; Prieto, Tabatha Gutierrez ; Farhat, Cecilia; Mangone, Flavia Regina Rotea; Batah, Sabrina Setembre ; Cruvinel, Heloísa Resende; Alda, Maiara Almeida; Monteiro, Jhonatas Sirino ; Padua, Adriana Inácio de; Morais, Sirlei Siani; Oliveira, Rogério Antônio de ; Santos, Marcel Koenigkam ; Martinez, José Antônio Baddini ; Setubal, João Carlos ; Rainho, Cláudia Aparecida ; Yoo, Hugo Hyung Bok ; Silva, Pedro Leme; Nagai, Maria Aparecida ; Capelozzi, Vera Luiza
Source: Frontiers in Pharmacology. Unidades: FMRP, IQ, FM, BIOINFORMÁTICA
Subjects: MICRORNAS, SEQUENCIAMENTO GENÉTICO, PLASMA, HIPERTENSÃO PULMONAR, TROMBOEMBOLISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FABRO, Alexandre Todorovic et al. Circulating plasma miRNA and clinical/hemodynamic characteristics provide additional predictive information about acute pulmonary thromboembolism, chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension. Frontiers in Pharmacology, v. 12, p. 1-12 art. 648769, 2021Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.648769. Acesso em: 16 nov. 2024.
APA
Fabro, A. T., Machado-Rugolo, J., Baldavira, C. M., Prieto, T. G., Farhat, C., Mangone, F. R. R., et al. (2021). Circulating plasma miRNA and clinical/hemodynamic characteristics provide additional predictive information about acute pulmonary thromboembolism, chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension. Frontiers in Pharmacology, 12, 1-12 art. 648769. doi:10.3389/fphar.2021.648769
NLM
Fabro AT, Machado-Rugolo J, Baldavira CM, Prieto TG, Farhat C, Mangone FRR, Batah SS, Cruvinel HR, Alda M A, Monteiro JS, Padua AI de, Morais SS, Oliveira RA de, Santos MK, Martinez JAB, Setubal JC, Rainho CA, Yoo HHB, Silva PL, Nagai MA, Capelozzi VL. Circulating plasma miRNA and clinical/hemodynamic characteristics provide additional predictive information about acute pulmonary thromboembolism, chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-12 art. 648769.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fphar.2021.648769
Vancouver
Fabro AT, Machado-Rugolo J, Baldavira CM, Prieto TG, Farhat C, Mangone FRR, Batah SS, Cruvinel HR, Alda M A, Monteiro JS, Padua AI de, Morais SS, Oliveira RA de, Santos MK, Martinez JAB, Setubal JC, Rainho CA, Yoo HHB, Silva PL, Nagai MA, Capelozzi VL. Circulating plasma miRNA and clinical/hemodynamic characteristics provide additional predictive information about acute pulmonary thromboembolism, chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-12 art. 648769.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fphar.2021.648769
Artigo de periodico
In silico analyses identify lncRNAs: WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors (2020)
Bastos, Daniel Rodrigues de; Nagai, Maria Aparecida
Source: PLOS ONE. Unidade: FM
Subjects: OLIGOPEPTÍDEOS, PROGNÓSTICO, PACIENTES, SOBREVIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASTOS, Daniel Rodrigues de e NAGAI, Maria Aparecida. In silico analyses identify lncRNAs: WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors. PLOS ONE, v. 15, n. 5, 2020Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0232284. Acesso em: 16 nov. 2024.
APA
Bastos, D. R. de, & Nagai, M. A. (2020). In silico analyses identify lncRNAs: WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors. PLOS ONE, 15( 5). doi:10.1371/journal.pone.0232284
NLM
Bastos DR de, Nagai MA. In silico analyses identify lncRNAs: WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors [Internet]. PLOS ONE. 2020 ; 15( 5):[citado 2024 nov. 16 ] Available from: https://doi.org/10.1371/journal.pone.0232284
Vancouver
Bastos DR de, Nagai MA. In silico analyses identify lncRNAs: WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors [Internet]. PLOS ONE. 2020 ; 15( 5):[citado 2024 nov. 16 ] Available from: https://doi.org/10.1371/journal.pone.0232284
Artigo de periodico
Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer (2020)
Parra, Edwin Roger; Jiang, Mei; Machado-rugolo, Juliana; Yaegashi, Lygia Bertalha; Prieto, Tabatha; Farhat, Cecília; Sá, Vanessa Karen de; Nagai, Maria Aparecida ; Lima, Vladmir Cláudio Cordeiro de; Takagaki, Teresa Yae; Terra, Ricardo Mingarini ; Fabro, Alexandre Todorovic ; Capelozzi, Vera Luiza
Source: Archives of Pathology & Laboratory Medicine. Unidades: FM, FMRP, FSP
Subjects: ANTÍGENOS, CARCINOMA, PULMÃO, NEOPLASIAS PULMONARES, LINFÓCITOS, IMUNOLOGIA, TAXA DE SOBREVIVÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARRA, Edwin Roger et al. Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer. Archives of Pathology & Laboratory Medicine, v. 144, n. 10, p. 1234-1244, 2020Tradução . . Disponível em: https://doi.org/10.5858/arpa.2019-0419-OA. Acesso em: 16 nov. 2024.
APA
Parra, E. R., Jiang, M., Machado-rugolo, J., Yaegashi, L. B., Prieto, T., Farhat, C., et al. (2020). Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer. Archives of Pathology & Laboratory Medicine, 144( 10), 1234-1244. doi:10.5858/arpa.2019-0419-OA
NLM
Parra ER, Jiang M, Machado-rugolo J, Yaegashi LB, Prieto T, Farhat C, Sá VK de, Nagai MA, Lima VCC de, Takagaki TY, Terra RM, Fabro AT, Capelozzi VL. Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer [Internet]. Archives of Pathology & Laboratory Medicine. 2020 ; 144( 10): 1234-1244.[citado 2024 nov. 16 ] Available from: https://doi.org/10.5858/arpa.2019-0419-OA
Vancouver
Parra ER, Jiang M, Machado-rugolo J, Yaegashi LB, Prieto T, Farhat C, Sá VK de, Nagai MA, Lima VCC de, Takagaki TY, Terra RM, Fabro AT, Capelozzi VL. Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer [Internet]. Archives of Pathology & Laboratory Medicine. 2020 ; 144( 10): 1234-1244.[citado 2024 nov. 16 ] Available from: https://doi.org/10.5858/arpa.2019-0419-OA
Artigo de periodico
Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer (2019)
Machado-rugolo, Juliana; Fabro, Alexandre Todorovic ; Ascheri, Daniel; Farhat, Cecilia; Ab'saber, Alexandre Muxfeldt; Sa, Vanessa Karen de; Nagai, Maria Aparecida; Takagaki, Teresa; Terra, Ricardo; Parra, Edwin Roger; Capelozzi, Vera Luiza
Source: Human pathology. Unidades: FM, FMRP
Subjects: NEOPLASIAS CEREBRAIS, METÁSTASE NEOPLÁSICA, NEOPLASIAS PULMONARES, IMUNOHISTOQUÍMICA, SEQUENCIAMENTO GENÉTICO, ONCOGENES, GENES SUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO-RUGOLO, Juliana et al. Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer. Human pathology, v. 83, p. 177-191, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.humpath.2018.08.026. Acesso em: 16 nov. 2024.
APA
Machado-rugolo, J., Fabro, A. T., Ascheri, D., Farhat, C., Ab'saber, A. M., Sa, V. K. de, et al. (2019). Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer. Human pathology, 83, 177-191. doi:10.1016/j.humpath.2018.08.026
NLM
Machado-rugolo J, Fabro AT, Ascheri D, Farhat C, Ab'saber AM, Sa VK de, Nagai MA, Takagaki T, Terra R, Parra ER, Capelozzi VL. Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer [Internet]. Human pathology. 2019 ; 83 177-191.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.humpath.2018.08.026
Vancouver
Machado-rugolo J, Fabro AT, Ascheri D, Farhat C, Ab'saber AM, Sa VK de, Nagai MA, Takagaki T, Terra R, Parra ER, Capelozzi VL. Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer [Internet]. Human pathology. 2019 ; 83 177-191.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.humpath.2018.08.026
Artigo de periodico
Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC) (2018)
Alcantara Filho, Paulo R. de; Mangone, Flavia R; Pavanelli, Ana C; Garcia, Simone A. de Bessa; Nonogaki, Suely; Andrade, Victor P. De; Nagai, Maria A.
Source: Breast cancer management. Unidade: FM
Subjects: NEOPLASIAS MAMÁRIAS, EXPRESSÃO GÊNICA, IMUNOHISTOQUÍMICA, PROTEÍNAS DO TECIDO CONJUNTIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALCANTARA FILHO, Paulo R. de et al. Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC). Breast cancer management, v. 7, n. 2, 2018Tradução . . Disponível em: https://doi.org/10.2217/bmt-2017-0019. Acesso em: 16 nov. 2024.
APA
Alcantara Filho, P. R. de, Mangone, F. R., Pavanelli, A. C., Garcia, S. A. de B., Nonogaki, S., Andrade, V. P. D., & Nagai, M. A. (2018). Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC). Breast cancer management, 7( 2). doi:10.2217/bmt-2017-0019
NLM
Alcantara Filho PR de, Mangone FR, Pavanelli AC, Garcia SA de B, Nonogaki S, Andrade VPD, Nagai MA. Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC) [Internet]. Breast cancer management. 2018 ; 7( 2):[citado 2024 nov. 16 ] Available from: https://doi.org/10.2217/bmt-2017-0019
Vancouver
Alcantara Filho PR de, Mangone FR, Pavanelli AC, Garcia SA de B, Nonogaki S, Andrade VPD, Nagai MA. Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC) [Internet]. Breast cancer management. 2018 ; 7( 2):[citado 2024 nov. 16 ] Available from: https://doi.org/10.2217/bmt-2017-0019
Artigo de periodico
Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands (2018)
Carlini, Maria Jose; Nagai, Maria Aparecida; Recouvreix, Maria Sol; Simian, Marina
Source: Bmc cancer. Unidade: FM
Subjects: RATOS, EXPRESSÃO GÊNICA, NEOPLASIAS MAMÁRIAS, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARLINI, Maria Jose et al. Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands. Bmc cancer, v. 18, 2018Tradução . . Disponível em: https://doi.org/10.1186/s12885-018-4550-z. Acesso em: 16 nov. 2024.
APA
Carlini, M. J., Nagai, M. A., Recouvreix, M. S., & Simian, M. (2018). Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands. Bmc cancer, 18. doi:10.1186/s12885-018-4550-z
NLM
Carlini MJ, Nagai MA, Recouvreix MS, Simian M. Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands [Internet]. Bmc cancer. 2018 ; 18[citado 2024 nov. 16 ] Available from: https://doi.org/10.1186/s12885-018-4550-z
Vancouver
Carlini MJ, Nagai MA, Recouvreix MS, Simian M. Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands [Internet]. Bmc cancer. 2018 ; 18[citado 2024 nov. 16 ] Available from: https://doi.org/10.1186/s12885-018-4550-z
Artigo de periodico
PHLDA1 (pleckstrin homology-like domain, family A, member 1) knockdown promotes migration and invasion of MCF10A breast epithelial cells (2018)
Bonatto, Naieli; Carlini, Maria Jose; Garcia, Simone Aparecida de Bessa; Nagai, Maria Aparecida
Source: Cell adhesion & migration. Unidade: FM
Subjects: NEOPLASIAS, EXPRESSÃO GÊNICA, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONATTO, Naieli et al. PHLDA1 (pleckstrin homology-like domain, family A, member 1) knockdown promotes migration and invasion of MCF10A breast epithelial cells. Cell adhesion & migration, v. 12, n. 1, p. 37-46, 2018Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/25547. Acesso em: 16 nov. 2024.
APA
Bonatto, N., Carlini, M. J., Garcia, S. A. de B., & Nagai, M. A. (2018). PHLDA1 (pleckstrin homology-like domain, family A, member 1) knockdown promotes migration and invasion of MCF10A breast epithelial cells. Cell adhesion & migration, 12( 1), 37-46. doi:10.1080/19336918.2017.1313382
NLM
Bonatto N, Carlini MJ, Garcia SA de B, Nagai MA. PHLDA1 (pleckstrin homology-like domain, family A, member 1) knockdown promotes migration and invasion of MCF10A breast epithelial cells [Internet]. Cell adhesion & migration. 2018 ; 12( 1): 37-46.[citado 2024 nov. 16 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25547
Vancouver
Bonatto N, Carlini MJ, Garcia SA de B, Nagai MA. PHLDA1 (pleckstrin homology-like domain, family A, member 1) knockdown promotes migration and invasion of MCF10A breast epithelial cells [Internet]. Cell adhesion & migration. 2018 ; 12( 1): 37-46.[citado 2024 nov. 16 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25547
Trabalho de evento-resumo periodico
Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients (2017)
Machado, Juliana; Nagai, Maria Aparecida; Fabro, Alexandre Todorovic; Capelozzi, Vera Luiza
Source: Journal of thoracic oncology. Conference titles: World conference on lun cancer - ASLC. Unidades: FM, FMRP
Subjects: NEOPLASIAS PULMONARES, ADENOCARCINOMA, PULMÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Juliana et al. Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S. Acesso em: 16 nov. 2024. , 2017
APA
Machado, J., Nagai, M. A., Fabro, A. T., & Capelozzi, V. L. (2017). Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
NLM
Machado J, Nagai MA, Fabro AT, Capelozzi VL. Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S955.[citado 2024 nov. 16 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
Vancouver
Machado J, Nagai MA, Fabro AT, Capelozzi VL. Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S955.[citado 2024 nov. 16 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
Trabalho de evento-resumo periodico
Role of cellular and extracellular Par-4 expression in tumor formation and drug sensitivity (2017)
Oliveira Filho, Lourival A.; Carlini, Maria José; Nagai, Maria Aparecida
Source: Cancer Research. Conference titles: AACR Special Conference on Translational Control of Cancer: A New Frontier in Cancer Biology and Therapy. Unidade: FM
Subjects: APOPTOSE, BIOMARCADORES, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA FILHO, Lourival A. e CARLINI, Maria José e NAGAI, Maria Aparecida. Role of cellular and extracellular Par-4 expression in tumor formation and drug sensitivity. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445. Acesso em: 16 nov. 2024. , 2017
APA
Oliveira Filho, L. A., Carlini, M. J., & Nagai, M. A. (2017). Role of cellular and extracellular Par-4 expression in tumor formation and drug sensitivity. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. doi:10.1158/1538-7445
NLM
Oliveira Filho LA, Carlini MJ, Nagai MA. Role of cellular and extracellular Par-4 expression in tumor formation and drug sensitivity [Internet]. Cancer Research. 2017 ; 77( 6):[citado 2024 nov. 16 ] Available from: https://doi.org/10.1158/1538-7445
Vancouver
Oliveira Filho LA, Carlini MJ, Nagai MA. Role of cellular and extracellular Par-4 expression in tumor formation and drug sensitivity [Internet]. Cancer Research. 2017 ; 77( 6):[citado 2024 nov. 16 ] Available from: https://doi.org/10.1158/1538-7445
Artigo de periodico
Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity (2017)
Garcia, Simone Aparecida de Bessa; Pavanelli, Ana Carolina; Melo, Natália Cruz e; Nagai, Maria Aparecida
Source: International Journal of Molecular Medicine. Unidade: FM
Subjects: NEOPLASIAS MAMÁRIAS, BIOMARCADORES, APOPTOSE, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARCIA, Simone Aparecida de Bessa et al. Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity. International Journal of Molecular Medicine, v. 39, n. 4, p. 809-818, 2017Tradução . . Disponível em: https://doi.org/10.3892/ijmm.2017.2900. Acesso em: 16 nov. 2024.
APA
Garcia, S. A. de B., Pavanelli, A. C., Melo, N. C. e, & Nagai, M. A. (2017). Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity. International Journal of Molecular Medicine, 39( 4), 809-818. doi:10.3892/ijmm.2017.2900
NLM
Garcia SA de B, Pavanelli AC, Melo NC e, Nagai MA. Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity [Internet]. International Journal of Molecular Medicine. 2017 ; 39( 4): 809-818.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3892/ijmm.2017.2900
Vancouver
Garcia SA de B, Pavanelli AC, Melo NC e, Nagai MA. Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity [Internet]. International Journal of Molecular Medicine. 2017 ; 39( 4): 809-818.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3892/ijmm.2017.2900
Artigo de periodico
Linear mRNA amplification approach for RNAseq from limited amount of RNA (2015)
Ferreira, Elisa Napolitano; Molina, Gustavo de Campos; Puga, Renato David; Nagai, Maria Aparecida; Campos, Antônio Hugo José Froes Marques; Guimarães, Gustavo Cardoso; Nunes, Diana Noronha; Pasqualini, Renata; Arap, Wadih; Brentani, Helena; Dias-Neto, Emmanuel; Brentani, Ricardo R.; Carraro, Dirce Maria
Source: Gene. Unidade: FM
Subjects: RNA, BIOINFORMÁTICA (ANÁLISE), NEOPLASIAS, EXPRESSÃO GÈNICA (OBSERVAÇÃO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Elisa Napolitano et al. Linear mRNA amplification approach for RNAseq from limited amount of RNA. Gene, v. 564, n. 2, p. 220-227, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.gene.2015.03.058. Acesso em: 16 nov. 2024.
APA
Ferreira, E. N., Molina, G. de C., Puga, R. D., Nagai, M. A., Campos, A. H. J. F. M., Guimarães, G. C., et al. (2015). Linear mRNA amplification approach for RNAseq from limited amount of RNA. Gene, 564( 2), 220-227. doi:10.1016/j.gene.2015.03.058
NLM
Ferreira EN, Molina G de C, Puga RD, Nagai MA, Campos AHJFM, Guimarães GC, Nunes DN, Pasqualini R, Arap W, Brentani H, Dias-Neto E, Brentani RR, Carraro DM. Linear mRNA amplification approach for RNAseq from limited amount of RNA [Internet]. Gene. 2015 ; 564( 2): 220-227.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.gene.2015.03.058
Vancouver
Ferreira EN, Molina G de C, Puga RD, Nagai MA, Campos AHJFM, Guimarães GC, Nunes DN, Pasqualini R, Arap W, Brentani H, Dias-Neto E, Brentani RR, Carraro DM. Linear mRNA amplification approach for RNAseq from limited amount of RNA [Internet]. Gene. 2015 ; 564( 2): 220-227.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.gene.2015.03.058
Parte de monografia/livro
Alterações genéticas no câncer (2015)
Encinas, Giselly; Mazzotti, Tatiane Furuya; Nagai, Maria Aparecida
Source: Fundamentos da oncologia molecular. Unidade: FM
Subjects: TÉCNICAS CITOLÓGICAS, MUTAÇÃO GENÉTICA, GENES SUPRESSORES DE TUMOR, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ENCINAS, Giselly e MAZZOTTI, Tatiane Furuya e NAGAI, Maria Aparecida. Alterações genéticas no câncer. Fundamentos da oncologia molecular. Tradução . São Paulo: Atheneu, 2015. . . Acesso em: 16 nov. 2024.
APA
Encinas, G., Mazzotti, T. F., & Nagai, M. A. (2015). Alterações genéticas no câncer. In Fundamentos da oncologia molecular. São Paulo: Atheneu.
NLM
Encinas G, Mazzotti TF, Nagai MA. Alterações genéticas no câncer. In: Fundamentos da oncologia molecular. São Paulo: Atheneu; 2015. [citado 2024 nov. 16 ]
Vancouver
Encinas G, Mazzotti TF, Nagai MA. Alterações genéticas no câncer. In: Fundamentos da oncologia molecular. São Paulo: Atheneu; 2015. [citado 2024 nov. 16 ]
Trabalho de evento-resumo periodico
Ipsilateral breast cancer recurrence in conservative treatment for locally advanced breast cancer (2015)
Carrara, G. F. A.; Neto, C. S.; Abrão-Machado, L. F.; Nunes, J. S.; Folgueira, M. A. A. K.; Brentani, M. M.; Vieira, R. A. C.
Source: The Breast. Conference titles: St. Gallen International Breast Cancer Conference. Unidade: FM
Subjects: CARCINOMA, RECIDIVA LOCAL DE NEOPLASIA, NEOPLASIAS DA MAMA (CIRURGIA;QUIMIOTERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARRARA, G. F. A. et al. Ipsilateral breast cancer recurrence in conservative treatment for locally advanced breast cancer. The Breast. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S0960-9776(15)70240-7. Acesso em: 16 nov. 2024. , 2015
APA
Carrara, G. F. A., Neto, C. S., Abrão-Machado, L. F., Nunes, J. S., Folgueira, M. A. A. K., Brentani, M. M., & Vieira, R. A. C. (2015). Ipsilateral breast cancer recurrence in conservative treatment for locally advanced breast cancer. The Breast. New York: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/S0960-9776(15)70240-7
NLM
Carrara GFA, Neto CS, Abrão-Machado LF, Nunes JS, Folgueira MAAK, Brentani MM, Vieira RAC. Ipsilateral breast cancer recurrence in conservative treatment for locally advanced breast cancer [Internet]. The Breast. 2015 ; 24( supl. 1): S96.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/S0960-9776(15)70240-7
Vancouver
Carrara GFA, Neto CS, Abrão-Machado LF, Nunes JS, Folgueira MAAK, Brentani MM, Vieira RAC. Ipsilateral breast cancer recurrence in conservative treatment for locally advanced breast cancer [Internet]. The Breast. 2015 ; 24( supl. 1): S96.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/S0960-9776(15)70240-7

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation